In a study of ovarian cancer (OV), CYP4B1 was identified as a differentially expressed gene in patients with advanced ovarian carcinoma, with significantly lower levels in those who experienced relapse following curative treatment. This evidence concerns the gene CYP4B1 and ovarian carcinoma.